Our experiments establish MDA-9 as a critical regulator of stem cell phenotypes in prostate cancer that are responsible for PCSC maintenance and survival through regulation of multiple stem-regulating molecules such as NOTCH1, C-myc, STAT3, NANOG, OCT4 and SOX2. This evidence concerns the gene NOTCH1 and prostate cancer.